LIA
RDY icon

Lynx Investment Advisory’s Dr. Reddy's Laboratories RDY Stock Holding History

Lynx Investment Advisory’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80
Closed -$1.22K – 628
2024
Q2 		$1.22K Buy
+80
New +$1.15K ﹤0.01% 620

Other funds holding RDY

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lynx Investment Advisory's RDY Position: Q3 2024 in Review

Lynx Investment Advisory sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 80 shares — an estimated $1.22K sold.

Lynx Investment Advisory first reported a position in RDY in Q2 2024 and held it in 1 quarter. The position peaked at $1.22K in Q2 2024. 227 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

  • Lynx Investment Advisory reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
  • Lynx Investment Advisory sold 80 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $1.22K.
  • Lynx Investment Advisory first reported a position in Dr. Reddy's Laboratories in Q2 2024 and held it in 1 quarter.
  • Lynx Investment Advisory's Dr. Reddy's Laboratories position peaked at $1.22K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.